Long-term outcome for Down syndrome patients with hematopoietic disorders

Long-term outcome for Down syndrome patients with hematopoietic disorders

Although Down syndrome (DS) patients have a higher risk of developing transient myeloproliferative disorder (TMD) and acute leukemia, very little data is available on long-term outcome in Taiwanese patients. The current study was designed to determine the clinical characteristics and treatment outco...

Full description

Bibliographic Details
Main Authors: Meng-Ju Li, Ni-Chung Lee, Yung-Li Yang, Hsiu-Ju Yen, Hsiu-Hao Chang, Yin-Hsiu Chien, Meng-Yao Lu, Shiann-Tarng Jou, Kai-Hsin Lin, Wuh-Liang Hwu, Dong-Tsamn Lin
Format: Article
Language:English
Published: Elsevier 2016-02-01
Series:Journal of the Formosan Medical Association
Subjects:
acute myeloid leukemia
Down syndrome
GATA1
myeloproliferative disorders
transcription factor
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664615000601

Internet

http://www.sciencedirect.com/science/article/pii/S0929664615000601

Similar Items